Diagnostic Approach to Pulmonary Embolism in Pregnant Patients

Initial Evaluation and Imaging

The American Thoracic Society recommends beginning with a chest X-ray as the first radiation-based imaging study, followed by lower extremity compression ultrasound if DVT symptoms are present, reserving CT pulmonary angiography (CTPA) for patients with abnormal chest X-rays or V/Q scanning for those with normal chest X-rays 1, 2
In pregnant patients, do not rely on D-dimer testing to exclude PE, particularly in the third trimester where only 4.2% of women with non-high pre-test probability have negative results 3, 4
The American Thoracic Society recommends against using D-dimer to exclude PE in pregnant women, prioritizing avoidance of false negatives over reducing unnecessary testing 1

If signs or symptoms of DVT are present, perform bilateral compression ultrasound (CUS) of lower extremities first 1, 2
If CUS is positive for proximal DVT, initiate therapeutic anticoagulation immediately without further imaging 1, 3
If no DVT symptoms are present, proceed directly to pulmonary vascular imaging rather than CUS, as this is more cost-effective 1, 2
Perform V/Q (perfusion) scintigraphy as the next imaging test rather than CTPA for patients with normal chest X-rays 1, 2
For patients with abnormal chest X-rays, perform CTPA as the next imaging test rather than V/Q scanning 1, 2, 5

If V/Q scan is non-diagnostic, proceed to CTPA rather than clinical management alone or digital subtraction angiography 1, 2, 5
If CTPA is indeterminate, initiate empiric therapeutic anticoagulation immediately while pursuing additional diagnostic testing if clinical suspicion is high and bleeding risk is low 5

Both CTPA and V/Q scanning expose the fetus to radiation doses well below the 50-100 mSv threshold for fetal complications 3, 4
Modern CTPA techniques with proper protocols result in negligible fetal risk 3, 4
Fetal radiation dose is slightly higher with V/Q scanning but still far below safety thresholds 5
Modern optimized CTPA exposes maternal breast tissue to 3-4 mGy, resulting in lifetime cancer risk increase of only 1.0003-1.0007 3, 4

Inconclusive imaging results occur more frequently in late pregnancy (43% of investigations) 3, 4
D-dimer utility is particularly limited in the third trimester 3, 4
Ensure pregnancy-optimized CTPA protocols are used to minimize non-diagnostic studies 4